戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 burden, is the most important mosquito-borne viral disease.
2 d contributes to tissue injury, exacerbating viral disease.
3  manage both aphids and aphid-vectored plant viral disease.
4  and evaluate antibodies against an emerging viral disease.
5 s, and this event plays an important role in viral disease.
6 ct cell types to orchestrate resistance to a viral disease.
7 nsplantation contribute to this high rate of viral disease.
8 a majority of infant hospitalizations due to viral disease.
9 eneficial role in the outcome of respiratory viral disease.
10 medical intervention for preventing epidemic viral disease.
11 gue, the most important mosquito-transmitted viral disease.
12 shown efficacy in experimental models of CNS viral disease.
13 ceptible mice from mousepox, an acute lethal viral disease.
14 V-1 to -4) cause the most important emerging viral disease.
15 can protect older individuals against severe viral disease.
16                NASH complicates hepatotropic viral disease.
17 potential therapeutics against this emerging viral disease.
18 Barr virus viremia (23% vs. 31%) or clinical viral disease.
19 t also powerfully shapes the presentation of viral disease.
20 ogen invasion and leading to protection from viral disease.
21 information to protect from, or treat, human viral disease.
22 serious bacterial infections concurrent with viral disease.
23 ines and antiviral therapies for this common viral disease.
24 n which apoE may determine the severity of a viral disease.
25  resulting plants did not suffer from severe viral disease.
26 menting roles in the resolution of influenza viral disease.
27 uence design to combat the wide landscape of viral disease.
28 ponders during outbreaks of high-consequence viral disease.
29 uired for productive infection and resultant viral disease.
30       Measles is a highly infectious, severe viral disease.
31 et for therapeutic intervention against this viral disease.
32  disease virus (FMDV) is a highly contagious viral disease.
33  deficiency that results in fatal and severe viral disease.
34  to enhanced susceptibility or resistance to viral diseases.
35 ions, and facilitates management of emerging viral diseases.
36 rkable successes in the control of childhood viral diseases.
37 lopment of novel antiviral therapies against viral diseases.
38  aegypti mosquitoes are important vectors of viral diseases.
39 hat may represent a new mechanism to prevent viral diseases.
40 gnificant promise for reducing the burden of viral diseases.
41 cytokines that are instrumental in combating viral diseases.
42 mportant foodborne bacterial, protozoal, and viral diseases.
43 SG15 deficiency but without unusually severe viral diseases.
44 tic intervention in diverse cancer types and viral diseases.
45 c vaccination in the treatment of persistent viral diseases.
46 ng many that are involved in pathogenesis of viral diseases.
47  demand to develop new strategies to control viral diseases.
48 ritical roles in the pathogenesis of chronic viral diseases.
49 lement large-scale molecular surveillance of viral diseases.
50 erefore a cure is lacking for many prevalent viral diseases.
51 lies and are known causative agents of fatal viral diseases.
52 is nonhuman primate model for AIDS and other viral diseases.
53 e immune system effectively protects us from viral diseases.
54 oxic T cells for immunotherapy of cancer and viral diseases.
55 tep towards the prevention and cure of human viral diseases.
56 rsitaires de Geneve, and Center for Emerging Viral Diseases.
57 the maintenance and transmission of zoonotic viral diseases.
58  host immune responses in many bacterial and viral diseases.
59 hepatitis B virus infection or other chronic viral diseases.
60 loping a fully informed approach to tackling viral diseases.
61 ectrum of pathologies, including cancers and viral diseases.
62 th the goal of enhancing their resistance to viral diseases.
63 y in 2 siblings presenting mycobacterial and viral diseases.
64 F5 gene may influence host susceptibility to viral diseases.
65 r tumorigenesis, development, metabolism and viral diseases.
66 stricts the number of effective vaccines for viral diseases.
67 may be a novel therapeutic target in chronic viral diseases.
68 ity contributes to neoplastic, metabolic and viral diseases.
69 rtain how immunity protects against systemic viral diseases.
70 on events are often associated with emergent viral diseases.
71 iruses are the second leading cause of human viral diseases.
72 t 80 years to control agricultural losses to viral diseases.
73 approach could be useful in the treatment of viral diseases.
74 ment with ribavirin and IFN in other chronic viral diseases.
75 ization for the treatment of HIV-1 and other viral diseases.
76 alth response to COVID-19 and other emerging viral diseases.
77 de drugs used in the treatment of cancer and viral diseases.
78  drugs to combat various forms of cancer and viral diseases.
79 te the prediction and prevention of emerging viral diseases.
80 ion and identification of various fungal and viral diseases.
81 with certain pathogens are less resistant to viral diseases.
82 ccessfully used for the treatment of several viral diseases.
83 and provide insights that may apply to other viral diseases.
84 nation against dengue virus (DENV) and other viral diseases.
85 ion and offer insights into the treatment of viral diseases.
86 o human health despite extensive research on viral diseases.
87 ation to facilitate the management of tomato viral diseases.
88 phylactic vaccine vectors to combat emerging viral diseases.
89  ISG15 deficiency and mycobacterial, but not viral, diseases.
90         A total of 70.5% of the children had viral disease, 22.0% had bacterial disease, and 10.9% ha
91 d individuals and correlated with markers of viral disease activity (viral load, CD8+ T cells, and CD
92 o that therapeutic interventions that reduce viral disease activity may not predictably reduce arteri
93 d-mouth disease (FMD) is a highly contagious viral disease affecting biungulate species.
94 (PPR) is a highly contagious and devastating viral disease affecting mainly sheep and goats, but also
95 f cassava brown streak disease, an important viral disease affecting one of Africa's staple crops.
96 swine fever (CSF), an economically important viral disease affecting the pig industry in many countri
97 T lymphocytes (CTLs) can effectively prevent viral disease after conventional stem cell transplantati
98                                    Recurrent viral disease after transplant remains a significant cha
99  virus-specific immunity to prevent or treat viral diseases after HSCT.
100  on the prevention and management of chronic viral diseases among injection drug users.
101         Anti-HMGB1 mitigated both early-life viral disease and asthma-like features, highlighting HMG
102 on, yet mice had considerable morbidity from viral disease and bacterial superinfection.
103 (ProTide) therapies used in the treatment of viral disease and cancer.
104 eting the hijacking of N-glycan synthesis in viral disease and cancer.
105 outcomes of liver transplantation, recurrent viral disease and malignancy remain major challenges.
106      Dengue is the most frequent hemorrhagic viral disease and re-emergent infection in the world.
107  subjects on suppressive HAART with residual viral disease and reservoirs can now be stratified.
108 ogenic host response in the setting of acute viral disease and that abrogation of this response ameli
109 definable risk of the transmission of severe viral disease and the induction of immunological reactio
110 e been implicated in the outcome of a number viral diseases and cancers.
111  develop cassava with enhanced resistance to viral diseases and insects pests, improved nutritional c
112  infection is the most common mosquito-borne viral disease, and it can cause life-threatening dengue
113 Dengue is the most important arthropod-borne viral disease, and it is a major public health problem i
114 cribing the transmission dynamics of chronic viral diseases, and for evaluating control strategies di
115 for causing extensive crop damage, vectoring viral diseases, and permanently destabilizing IPM system
116 essfully developed as vaccines against other viral diseases, and safety concerns have recently been a
117                               Mosquito-borne viral diseases are a major concern of global health and
118                               Mosquito borne viral diseases are an emerging threat as evident from th
119                    Antibiotic resistance and viral diseases are rising around the world and are becom
120 neration of drug resistance in bacterial and viral diseases as well as cancers, and the development o
121 gely unexploited strategy against infectious viral disease; as viruses infect cells, they abnormally
122                          Measles is an acute viral disease associated both with immune suppression an
123 ic targets for the neoplastic, metabolic and viral diseases associated with JunD/AP-1 expression.
124 tant considerations for therapies of chronic viral diseases, autoimmune diseases, and cancers.
125  Aedes aegypti is a major vector of numerous viral diseases, because it requires a blood meal to faci
126 multidimensional effects of HLA molecules in viral disease become apparent.
127 de new tools for prophylaxis and therapy for viral diseases but also identify conserved epitopes that
128 es or vaccine candidates exist against these viral diseases, but all could potentially be improved if
129  killer (NK) cells confer resistance to many viral diseases, but in only a few instances the molecula
130 s for the prevention and treatment of severe viral diseases, but their long development timeframes li
131 progression to a severe, extreme form of the viral disease by modulating the patients' immune landsca
132 c T cells and indicates that T cell-mediated viral disease can occur even under conditions of immunos
133 s essential to limit such threats, but plant viral diseases can be extremely challenging to diagnose.
134  emerging mosquito-borne zoonotic infectious viral disease caused by the RVF virus (RVFV) (Bunyavirid
135       Dengue is the most common vector-borne viral disease, causing nearly 400 million infections yea
136     Treatment in most cases of bacterial and viral diseases consists of correcting fluid loss and ele
137 evention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for
138 ch more than half a million succumbed to the viral disease, COVID-19.
139    Infectious pancreatic necrosis (IPN) is a viral disease currently presenting a major problem in th
140 teins provide new targets for disrupting the viral disease cycle in the arthropod vector and could be
141                                              Viral diseases discussed include influenza, hepatitis B,
142 t of successful vaccine strategies for other viral diseases disproportionately affecting the elderly,
143 sical swine fever (CSF), a highly contagious viral disease endangering the pig industry in many count
144  Rift Valley fever (RVF) is a mosquito-borne viral disease endemic to Africa, characterized by high r
145 Congo hemorrhagic fever, a highly contagious viral disease endemic to more than 30 countries, has lim
146                   We report 2 cases of Ebola viral disease (EVD) in pregnant women who survived, init
147 environments, with important implications in viral disease evolution.
148 ombocytopenia syndrome (SFTS) is an emerging viral disease for which there are currently no therapeut
149 d the ecological and evolutionary drivers of viral diseases from data on disease incidence as well as
150                    Licensed vaccines against viral diseases generate antibodies that neutralize the i
151 in the pathogenesis of a highly lethal human viral disease, hantavirus pulmonary syndrome (HPS).
152               The design of vaccines against viral disease has evolved considerably over the past 50
153 ssemination and pathogenesis of a tick-borne viral disease has never been attempted before.
154            The seasonal cycle of respiratory viral diseases has been widely recognized for thousands
155  specificity for the identification of these viral diseases; however, the preparation of cell culture
156 e context of addressing a fictional emerging viral disease, I describe the process of discovery, from
157 fits-all approach toward mitigating negative viral disease impacts on diverse agroecological producti
158  information to facilitate the management of viral diseases.IMPORTANCE Tomato is an important source
159  to be the causative agent of a serious duck viral disease in Asia.
160 B, which may be of value to prevent or treat viral disease in CB transplant recipients.
161  and a prominent cause of insect-transmitted viral disease in Central and South America.
162          H7N9 avian influenza is an emerging viral disease in China caused by avian influenza A (H7N9
163 ing adenoviremia and preventing disseminated viral disease in hematopoietic cell transplant (HCT) rec
164     Dengue is the most common mosquito-borne viral disease in human beings, and vector control has no
165 NV) is the most prevalent insect-transmitted viral disease in humans globally, and currently no speci
166  Dengue is the most prevalent mosquito-borne viral disease in humans, and the lack of early prognosti
167     Dengue is the most common mosquito-borne viral disease in humans.
168 y within IFITM3 determines susceptibility to viral disease in humans.
169 ENV-4), is a highly prevalent mosquito-borne viral disease in humans.
170 herapeutic approaches to combat this painful viral disease in humans.
171                                              Viral disease in Ifitm3-/- mice was accompanied by eleva
172 ogical and effective way of combating severe viral disease in immunocompromised patients in multiple
173 omegalovirus (HCMV) remains a major cause of viral disease in immunosuppressed transplant patients.
174                          The transmission of viral disease in the operating room is an evolving probl
175 ible could improve assessment of severity of viral disease in the population.
176 Hepatitis C is the most prevalent bloodborne viral disease in the United States and the deadliest.
177  cell survival and increased the severity of viral disease in vivo.
178 enza impressively reflects the paradigm of a viral disease in which continued evolution of the virus
179  potent immune responses and protect against viral diseases in animal models.
180                                              Viral diseases in aquaculture are challenging because th
181 ) have been associated with epidemics of two viral diseases in Eastern Africa.
182 evelopment of new strategies for controlling viral diseases in human populations and agroecosystems.
183 trable antiviral regimen against respiratory viral diseases in humans.
184 irus (HBV) represents one of the most common viral diseases in humans.
185 rapeutic candidate for COVID-19 and emerging viral diseases in the future.
186 e is one of the most widespread vector-borne viral diseases in the world.
187  that we tested, consistent with the lack of viral diseases in these patients.
188 a unique approach for treatment that reduces viral diseases in vivo.
189  (PBFD), one of the most common and emergent viral diseases in wild parrots (Psittaciformes) that is
190 o economically important yield losses due to viral diseases, including cassava brown streak disease a
191 R) has become the primary method to diagnose viral diseases, including severe acute respiratory syndr
192 to be an effective means for preventing many viral diseases, including smallpox, polio, measles, mump
193 arch for novel therapeutic interventions for viral disease is a challenging pursuit, hallmarked by th
194 dely adopted tool, transforming the way that viral disease is researched, monitored, and treated.
195                                     However, viral disease is still a major factor limiting tomato pr
196                      Early diagnosis of this viral disease is very important since it can prevent lot
197 tigation of PD-1 pathway blockade in chronic viral disease is warranted.
198 e epidemiology of emerging Aedes-transmitted viral diseases is recognized but not fully understood.
199  Adenovirus infection, which is a waterborne viral disease, is one of the most prevelant causes of hu
200 case fatality rates (30 to 50%) of any acute viral disease known.
201  drugs are needed to treat the ever-changing viral disease landscape.
202 antiviral drugs treat only a small number of viral diseases, leaving many patients with established o
203 eful for informing public health response to viral diseases like COVID-19 caused by SARS-CoV-2.
204 les of the ESCRTs in cellular physiology and viral disease make it imperative to understand the membr
205 e of highly endemic parasitic, bacterial and viral diseases makes individuals and populations vulnera
206 d salmon, emphasizes the potential role that viral disease may play in the population dynamics of wil
207 matitis virus (VSV) are effective in several viral disease models.
208 development of vaccines and therapeutics for viral diseases, models that can accurately recapitulate
209  to evaluate in cases of either bacterial or viral disease monitoring.
210 xplain the relatively mild susceptibility to viral disease observed in STAT3- and IL-21R-deficient su
211 no disease in the valG group but two serious viral diseases occurred in the placebo group (one CMV; o
212 the impact on the spread of a mosquito-borne viral disease of a strategy that releases adult male ins
213 ek's disease (MD) is a devastating oncogenic viral disease of chickens caused by Gallid herpesvirus 2
214 d-mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed ungulates that can lead t
215 gical agent of a contagious and often lethal viral disease of domestic pigs that has significant econ
216 ease virus (FMDV) causes a highly contagious viral disease of even-toed ungulates and is one of the m
217           Dengue disease is a mosquito-borne viral disease of expanding geographical range and incide
218  leafroll is the most complex and intriguing viral disease of grapevine (Vitis spp.).
219      Chronic bee paralysis is a well-defined viral disease of honey bees with a global distribution t
220 evalent and rapidly spreading mosquito-borne viral disease of human beings.
221 ), make it the most important mosquito-borne viral disease of humans (50 to 100 million infections/ye
222                     Dengue is a vector-borne viral disease of humans that endemically circulates in m
223 1-4) cause the most prevalent mosquito-borne viral disease of humans worldwide.
224 e fever is the most frequent arthropod-borne viral disease of humans, with almost half of the world's
225 -4) cause the most important arthropod-borne viral disease of humans.
226 he agent of the most widespread vector-borne viral disease of humans.
227  the pathogenesis of bronchiolitis, a common viral disease of infancy, and a recent U.K. family study
228         Dengue is a systemic arthropod-borne viral disease of major global public health importance.
229 tive agent of a severe and highly contagious viral disease of pigs that poses serious economic conseq
230 Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater t
231 ver (CSF) is a notifiable, highly contagious viral disease of swine which results in severe welfare a
232                                              Viral diseases of crustaceans are increasingly recognise
233 urveillance for CCoV variants and intestinal viral diseases of global significance.
234      Mosquitoes are vectors of parasitic and viral diseases of immense importance for public health.
235 ge species serving as vector for a number of viral diseases of livestock, including Bluetongue, and A
236  in elucidating the underlying mechanisms of viral diseases of the CNS.
237 mphopenia, especially in the case of chronic viral diseases or cancer immunotherapy.
238 in which genomic data can help us understand viral disease outbreaks, we aim to provide a resource th
239 nalysis is a powerful tool for understanding viral disease outbreaks.
240  and cropping systems that favor destructive viral disease outbreaks.
241 g trend, including a shift from parasitic to viral diseases over time.
242                                              Viral disease, particularly cytomegalovirus infection, r
243 amental requirement for our understanding of viral disease pathogenesis.
244                                 Vector-borne viral diseases pose an urgent public health challenge, p
245 the first time in a wild vertebrate facing a viral disease possibly due to herpesvirus (i) whether ne
246 abolic and endocrine mechanistic link to the viral disease process.
247 bitors has implications for the treatment of viral disease.Production of reactive oxygen species is a
248                                              Viral diseases provide a major challenge to twenty-first
249 found in the context of severe bacterial and viral disease, recurrent hepatopathy and encephalopathy,
250 thology can be leveraged to decipher the non-viral disease-relevant mechanisms.
251 e against human filovirus diseases and other viral diseases representing major public health threats.
252 ss HLA class supertype boundaries in a human viral disease setting.
253 l response, which together control influenza viral disease severity.
254 own to be protective in the setting of other viral diseases such as Ebola infections.
255 inical efficacy for the treatment of chronic viral diseases such as hepatitis B virus, human papillom
256                 Simple models of therapy for viral diseases such as hepatitis C virus (HCV) or human
257 show great promise as vaccines against other viral diseases such as human immunodeficiency virus type
258 ell immunity is critical for protection from viral disease, such as that caused by the human immunode
259                    Preclinical work in other viral diseases, such as dengue, has demonstrated the pot
260 aged hosts are generally more susceptible to viral diseases than the young, specific dysfunctions of
261 streak disease (CBSD) is a rapidly spreading viral disease that affects a major food security crop in
262                   Dengue is a mosquito-borne viral disease that afflicts millions of individuals worl
263  wheat mosaic virus (SBWMV) causes a serious viral disease that can significantly reduce grain yield
264  Yellow fever (YF) is a mosquito-transmitted viral disease that causes tens of thousands of deaths ea
265                       Zika, a mosquito-borne viral disease that emerged in South America in 2015, was
266                    Smallpox is an eradicated viral disease that has re-emerged as a potential bioterr
267        African swine fever (ASF) is a severe viral disease that is currently spreading among domestic
268 esults suggest that HS binding may attenuate viral disease that is dependent on high-titer viremia; h
269 Valley fever (RVF) is a mosquito-transmitted viral disease that is endemic to Africa and that has the
270 s), is one of the most severe and widespread viral diseases that adversely reduces maize yield and th
271 outh disease (FMD) is one of the most feared viral diseases that can affect livestock.
272 ergence of several novel diseases, including viral diseases, that have caused serious problems for pr
273                    Compared to the number of viral diseases, the number of available vaccines is mini
274 unds may alter treatment paradigms for acute viral disease through development of a single-dose thera
275  that the use of these agents may facilitate viral disease; thus, they should not be used in high-ris
276 ge-dependent increase in susceptibility to a viral disease to a specific defect of NK cells, opening
277 ls that are resistant to PRRS, the costliest viral disease to ever face the swine industry.
278   Because of the threat of emerging wildlife viral diseases to global biodiversity, fundamental resea
279 nization classifies zika as the most harmful viral disease today and considers the development of new
280         Hepatitis A is a vaccine-preventable viral disease transmitted by the fecal-oral route.
281                            Rabies is a fatal viral disease typically transmitted through the bite of
282 IFNs are used as therapeutic agents to treat viral diseases, understanding their antiviral mechanisms
283  the potential exists to eradicate a chronic viral disease using combination therapies that contain o
284 ap, alterations in source-sink patterns, and viral diseases vectored by aphids, which are phloem-feed
285                     Dengue, a mosquito-borne viral disease, was designated a World Health Organizatio
286 sms of the innate resistance of bats against viral diseases, we might gain important insights into ho
287 confer protection against severe respiratory viral disease when humoral immunity is overcome.
288 ing markedly from viruses causing short-term viral diseases, which degrade mitochondrial DNA.
289 he epigenetic therapies for cancer and other viral diseases, which may open a new venue to cure chron
290    Rift Valley fever (RVF) is a vector-borne viral disease widespread in Africa.
291 nderstanding of the role of SOCS proteins in viral diseases will be essential in our struggle to modu
292                   Dengue is an acute febrile viral disease with >100 million infections occurring eac
293    Infectious pancreatic necrosis (IPN) is a viral disease with a significant negative impact on the
294                               Avian pox is a viral disease with a wide host range.
295 n, and has implications for the treatment of viral disease with adoptively transferred CD8+ T cells.
296 n-Congo hemorrhagic fever (CCHF) is a severe viral disease with high fatality rate.
297 openia syndrome (SFTS) is a novel tick-borne viral disease with high mortality.
298 ely to better prepare for and respond to new viral diseases with a focus on new paradigms for vaccine
299 Monitoring the emergence and re-emergence of viral diseases with the goal of containing the spread of
300 tor (TCR) usage is relatively common in many viral diseases yet surprising in the context of the larg

 
Page Top